Warrants Finder
Your selection:
317 Results
| MN022K | Bristol-Myers Squibb Co./OS/Call [50]/MS | - | - | 50.000 | call | Bristol-Myers Squibb Co. | - | 39.406% | 0.722 | -0.005 | 2.738 | 12/17/2027 | 0.100 | Morgan Stanley | ||
| MR16M1 | Bristol-Myers Squibb Co./OS/Call [50]/MS | - | - | 50.000 | call | Bristol-Myers Squibb Co. | - | 38.722% | 0.771 | -0.007 | 3.484 | 03/19/2027 | 0.100 | Morgan Stanley | ||
| FA1BQN | Bristol-Myers Squibb Co./OS/Call [50]/SOC | - | - | 50.000 | call | Bristol-Myers Squibb Co. | - | 38.776% | 0.787 | -0.007 | 3.814 | 01/15/2027 | 0.100 | Société Générale | ||
| FA53CA | Bristol-Myers Squibb Co./OS/Call [50]/SOC | - | - | 50.000 | call | Bristol-Myers Squibb Co. | - | 38.521% | 0.813 | -0.009 | 3.983 | 12/18/2026 | 0.100 | Société Générale | ||
| FD1Y4N | Bristol-Myers Squibb Co./OS/Call [50]/SOC | - | - | 50.000 | call | Bristol-Myers Squibb Co. | - | 37.444% | 0.774 | -0.007 | 3.558 | 03/19/2027 | 0.100 | Société Générale | ||
| FD1YPK | Bristol-Myers Squibb Co./OS/Call [50]/SOC | - | - | 50.000 | call | Bristol-Myers Squibb Co. | - | - | - | - | - | 09/18/2026 | 0.100 | Société Générale | ||
| UN3J2V | Bristol-Myers Squibb Co./OS/Call [50]/UniCredit | - | - | 50.000 | call | Bristol-Myers Squibb Co. | - | 40.437% | 0.783 | -0.008 | 3.763 | 01/13/2027 | 0.100 | Unicredit | ||
| UN9X0M | Bristol-Myers Squibb Co./OS/Call [50]/UniCredit | - | - | 50.000 | call | Bristol-Myers Squibb Co. | - | 35.948% | 0.755 | -0.006 | 3.324 | 06/16/2027 | 0.100 | Unicredit | ||
| VH50E9 | Bristol-Myers Squibb Co./OS/Call [50]/VONT | - | - | 50.000 | call | Bristol-Myers Squibb Co. | - | 41.550% | 0.783 | -0.008 | 3.644 | 01/15/2027 | 0.100 | Vontobel | ||
| MK5REM | Bristol-Myers Squibb Co./OS/Call [52,5]/MS | - | - | 52.500 | call | Bristol-Myers Squibb Co. | - | 39.360% | 0.754 | -0.010 | 4.232 | 12/18/2026 | 0.100 | Morgan Stanley | ||
| MK9J50 | Bristol-Myers Squibb Co./OS/Call [52,5]/MS | - | - | 52.500 | call | Bristol-Myers Squibb Co. | - | 36.285% | 0.716 | -0.006 | 3.454 | 06/17/2027 | 0.100 | Morgan Stanley | ||
| MM5G89 | Bristol-Myers Squibb Co./OS/Call [52,5]/MS | - | - | 52.500 | call | Bristol-Myers Squibb Co. | - | 40.200% | 0.836 | -0.016 | 5.521 | 09/18/2026 | 0.100 | Morgan Stanley | ||
| PJ8XN3 | Bristol-Myers Squibb Co./OS/Call [52]/BNP | - | - | 52.000 | call | Bristol-Myers Squibb Co. | - | 39.032% | 0.857 | -0.015 | 5.453 | 09/18/2026 | 0.100 | BNP Paribas | ||
| PK34Q4 | Bristol-Myers Squibb Co./OS/Call [52]/BNP | - | - | 52.000 | call | Bristol-Myers Squibb Co. | - | 39.360% | 0.765 | -0.010 | 4.210 | 12/18/2026 | 0.100 | BNP Paribas | ||
| JY1EK9 | Bristol-Myers Squibb Co./OS/Call [54]/JPMD | - | - | 54.000 | call | Bristol-Myers Squibb Co. | - | 35.346% | 0.740 | -0.010 | 4.728 | 12/18/2026 | 0.100 | JP Morgan | ||
| FD1YPN | Bristol-Myers Squibb Co./OS/Call [54]/SOC | - | - | 54.000 | call | Bristol-Myers Squibb Co. | - | 39.360% | 0.697 | -0.009 | 4.281 | 01/15/2027 | 0.100 | Société Générale | ||
| PG5HFC | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 38.266% | 0.696 | -0.011 | 4.717 | 12/18/2026 | 0.100 | BNP Paribas | ||
| PL1KQH | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 39.123% | 0.676 | -0.010 | 4.412 | 01/15/2027 | 0.100 | BNP Paribas | ||
| PL678M | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.842% | 0.774 | -0.017 | 6.599 | 09/18/2026 | 0.100 | BNP Paribas | ||
| PG1RGP | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 35.966% | 0.665 | -0.007 | 3.704 | 06/17/2027 | 0.100 | BNP Paribas | ||
| PK0DLV | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 37.408% | 0.674 | -0.008 | 4.046 | 03/19/2027 | 0.100 | BNP Paribas | ||
| PK42U0 | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.477% | 0.652 | -0.006 | 3.378 | 09/17/2027 | 0.100 | BNP Paribas | ||
| PK42U2 | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.641% | 0.647 | -0.005 | 3.137 | 12/17/2027 | 0.100 | BNP Paribas | ||
| PK50NM | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 37.481% | 0.642 | -0.005 | 3.030 | 01/21/2028 | 0.100 | BNP Paribas | ||
| PK51Y8 | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.906% | 0.645 | -0.005 | 2.940 | 03/17/2028 | 0.100 | BNP Paribas | ||
| JF29MP | Bristol-Myers Squibb Co./OS/Call [55]/JPM | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 35.747% | 0.703 | -0.011 | 4.952 | 12/18/2026 | 0.100 | JP Morgan | ||
| JF3DN2 | Bristol-Myers Squibb Co./OS/Call [55]/JPM | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.787% | 0.681 | -0.009 | 4.616 | 01/15/2027 | 0.100 | JP Morgan | ||
| JH4RYN | Bristol-Myers Squibb Co./OS/Call [55]/JPM | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 34.013% | 0.796 | -0.015 | 6.702 | 09/18/2026 | 0.100 | JP Morgan | ||
| MJ8503 | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.076% | 0.710 | -0.011 | 4.829 | 12/18/2026 | 0.100 | Morgan Stanley | ||
| MK9J51 | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.203% | 0.664 | -0.007 | 3.691 | 06/17/2027 | 0.100 | Morgan Stanley | ||
| MM5G8A | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 37.390% | 0.769 | -0.018 | 6.555 | 09/18/2026 | 0.100 | Morgan Stanley | ||
| MN022L | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 37.645% | 0.654 | -0.005 | 3.048 | 12/17/2027 | 0.100 | Morgan Stanley | ||
| MN6CP3 | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.751% | 0.675 | -0.008 | 4.099 | 03/19/2027 | 0.100 | Morgan Stanley | ||
| SX5KV0 | Bristol-Myers Squibb Co./OS/Call [55]/SOC | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 38.667% | 0.675 | -0.010 | 4.459 | 01/15/2027 | 0.100 | Société Générale | ||
| FA53CB | Bristol-Myers Squibb Co./OS/Call [55]/SOC | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.222% | 0.704 | -0.011 | 4.896 | 12/18/2026 | 0.100 | Société Générale | ||
| FD1Y4P | Bristol-Myers Squibb Co./OS/Call [55]/SOC | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 35.127% | 0.680 | -0.008 | 4.229 | 03/19/2027 | 0.100 | Société Générale | ||
| FD5GU5 | Bristol-Myers Squibb Co./OS/Call [55]/SOC | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 34.397% | 0.792 | -0.016 | 6.670 | 09/18/2026 | 0.100 | Société Générale | ||
| UN3U23 | Bristol-Myers Squibb Co./OS/Call [55]/UniCredit | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 37.399% | 0.687 | -0.009 | 4.509 | 01/13/2027 | 0.100 | Unicredit | ||
| VJ3CBV | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 36.605% | 0.701 | -0.011 | 4.870 | 12/18/2026 | 0.100 | Vontobel | ||
| VY3747 | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 39.123% | 0.676 | -0.010 | 4.412 | 01/15/2027 | 0.100 | Vontobel | ||
| VY46PN | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 35.117% | 0.673 | -0.007 | 3.725 | 06/17/2027 | 0.100 | Vontobel | ||
| VY8B9B | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 35.802% | 0.678 | -0.008 | 4.171 | 03/19/2027 | 0.100 | Vontobel | ||
| VY8CG2 | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55.000 | call | Bristol-Myers Squibb Co. | - | 35.492% | 0.781 | -0.016 | 6.558 | 09/18/2026 | 0.100 | Vontobel | ||
| JE73P5 | Bristol-Myers Squibb Co./OS/Call [56]/JPMD | - | - | 56.000 | call | Bristol-Myers Squibb Co. | - | 35.054% | 0.658 | -0.008 | 4.347 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE8XWS | Bristol-Myers Squibb Co./OS/Call [56]/JPMD | - | - | 56.000 | call | Bristol-Myers Squibb Co. | - | 36.349% | 0.655 | -0.009 | 4.805 | 01/15/2027 | 0.100 | JP Morgan | ||
| JY0S65 | Bristol-Myers Squibb Co./OS/Call [56]/JPMD | - | - | 56.000 | call | Bristol-Myers Squibb Co. | - | 35.127% | 0.678 | -0.011 | 5.187 | 12/18/2026 | 0.100 | JP Morgan | ||
| JY2267 | Bristol-Myers Squibb Co./OS/Call [56]/JPMD | - | - | 56.000 | call | Bristol-Myers Squibb Co. | - | 37.061% | 0.781 | -0.023 | 8.608 | 08/21/2026 | 0.100 | JP Morgan | ||
| FA1BQP | Bristol-Myers Squibb Co./OS/Call [56]/SOC | - | - | 56.000 | call | Bristol-Myers Squibb Co. | - | 38.521% | 0.652 | -0.010 | 4.594 | 01/15/2027 | 0.100 | Société Générale | ||
| MK5RER | Bristol-Myers Squibb Co./OS/Call [57,5]/MS | - | - | 57.500 | call | Bristol-Myers Squibb Co. | - | 36.276% | 0.634 | -0.012 | 5.314 | 12/18/2026 | 0.100 | Morgan Stanley | ||
| MK9J52 | Bristol-Myers Squibb Co./OS/Call [57,5]/MS | - | - | 57.500 | call | Bristol-Myers Squibb Co. | - | 35.492% | 0.619 | -0.007 | 3.941 | 06/17/2027 | 0.100 | Morgan Stanley |